Study on the queue of autoimmune dermatitis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500101303

Enrollment

Unknown

Registered

2025-04-23

Start date

2025-05-01

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune dermatitis

Interventions

Autoimmune dermatitis group:none

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with autoimmune dermatitis by clinical and related examinations; age 18-75; signed informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria: coexisting with other severe autoimmune diseases; used immunosuppressants or biological agents in the past 3 months; pregnant or lactating women; patients with mental illness who cannot cooperate with researchers.

Design outcomes

Primary

Measure	Time frame
Blood routine;immunological index;inflammatory factor;Severity rating;	—

Countries

China

Contacts

Public ContactChen Xinke

Jining Medical College Affiliated Hospital

chenxinke2002@163.com+86 135 0897 3010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026